Monday, July 16, 2018

The Pickled Practitioner reports on Infirma's NOACs

Imagine my surprise (writes the pickled practitioner) when, on trying to stagger to the nurses' station for some spirit to rub the final bits of last evening's vomit off my shoes, I overheard the trainees discussing logistics for a weekend event. Ever an academician and notwithstanding their tendency to bandy unpleasant words in their conversation with me, words like 'smell', and 'sobriety', I managed to glean sufficient information to learn that it was about a company introducing a line of NAOCs (not important) and was to happen this weekend at a resort on ECR (important) and there was to be an open bar (vitally important).


Infirma pharmaceuticals is one of those new and effervescent companies that are springing up all over India in an attempt to corner the sizeable Indian and the international pharma market. Based out of xxxxxxx (ask tamisevlan0, their relatively recent inception gives them many advantages, like being able to invite grizzled old physicians like me to lend gravitas to their events (without hasty and unwise presumptions that other, older firms have a tendency to make, like banning me from all their events because of minor transgressions like causing a small conflagration by pouring my drink into their projector in an attempt to cool it down - but more on that some other time). A quick phone call to their PR department on a phone borrowed from a passing patient and it was all arranged. I was briefly apprehensive that in their hurry to establish themselves in a crowded market space they might have hired someone familiar with me, but it turns out it was all for nothing as the lovely lady even arranged for a company car to pick me up on the morning of the event from Jill-jill wines near the hospital to drive me to the venue.


Although there was some confusion with my location that morning, I must appreciate the perseverance of the chauffeur who managed to find me draped over a nearby compound wall, having been escorted there by the surprisingly muscular management of jill-jill wines - who had taken offence to my suggestion that asking me to pay for masala omelettes was an unnecessary formality given the length of my association with them. I was grateful to be helped into the waiting car, and to have my personal effects handed to me, but not nearly as grateful to realise that the five cleverly trousered airline-sized bottles of rum that I always carry as a precaution were still there with me.


Some time later, I arrived at the place suitably refreshed; and the gentleman chauffeur dropped me off at the reception before heading off presumably to try and wipe down the inside of his car's door, and see if he could scrub the remnants of what looked suspiciously like masala omelette off - the parts that I hadn't successfully managed to direct outside the car, that is. Brief initial misunderstanding of mistaken identity (where I was thought to be the beggar from across the road) cleared up, I was ushered by the charming ladies from reception to where the event was just beginning.


I was pleased to note that I was attended to almost immediately by the resort's wait staff serving me with a choice of drinks, ignoring the event organiser's frantic hand signals to keep them away from me. The table I was sat at was remarkably free from impertinent juniors and nosy colleagues with a proclivity towards irrelevant questions like "Is that sexual harassment case over?" The next half an hour passed in a pleasant blur of colourful spirits, slides, and graphs - and monotonous speakers droning on about Infirma and their new line of NACOs. Soon, it was time for the customary question and answer session, and as someone always keen to contribute to the industry, not to mention liven up proceedings, I put my hand up and asked after the principal investigator in the trial, Dr. Shetty. For some reason, however - "Kya re, Shetty a?" was deemed to be an improper form of address by the organisers and rather inexplicably the more I repeated my question loudly in an attempt to clarify, the unhappier the presenter became. It was then that I was conveyed off the premises by some other resort staff decidedly less charming and more masculine than the ladies I'd encountered earlier in the day. I was relieved to be assured that the Infirma branded pens, paperweights, and notepads I had collected to sell on ebay would be delivered to me at a later date, although I have yet to receive them.


To sum up, the event was rather well organised (and lubricated!) and I have no reservations in attesting Infirma as a leader of and a credit to the Indian pharmaceutical industry. At the risk of appearing to have copy pasted from a PR handout, Infirma strives to be at the bleeding edge of breakthroughs in the research, development, and manufacture of pharmaceutical products for the Indian market and beyond 2 . Our new line of NOACs strives to set a fresh benchmark for efficacy 3 in the prophylaxis of thrombotic events 7 specifically in Continued on Page 3 Please Turn Over © InfirmaTM Pharmaceuticals 2018